Doxazosin
- Product NDC
- 0904-5523
- 11-digit product format
- 009045523
- Labeler code
- 0904
- Product ID
- 0904-5523_ec0e1a20-88d4-457b-88fa-eff3071d0b9f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Major Pharmaceuticals
- Application
- ANDA075580
- Marketing category
- ANDA
- Marketing start
- 2011-07-14
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075580-001 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2000-10-18 | |
| A075580-002 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2000-10-18 | |
| A075580-003 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2000-10-18 | |
| A075580-004 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2000-10-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A075580-001 | AB |
| A075580-002 | AB |
| A075580-003 | AB |
| A075580-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A075580-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2000-10-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A075580-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2000-10-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A075580-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2000-10-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A075580-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2000-10-18 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075580-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2000-10-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075580-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2000-10-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075580-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2000-10-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075580-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2000-10-18 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A075580-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2000-10-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A075580-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2000-10-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A075580-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2000-10-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A075580-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2000-10-18 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075580-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2000-10-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075580-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2000-10-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075580-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2000-10-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075580-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2000-10-18 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075580-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2000-10-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075580-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2000-10-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075580-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2000-10-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075580-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2000-10-18 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075580-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2000-10-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075580-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2000-10-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075580-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2000-10-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075580-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2000-10-18 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075580-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2000-10-18 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075580-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2000-10-18 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075580-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2000-10-18 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075580-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2000-10-18 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075580-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2000-10-18 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075580-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2000-10-18 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075580-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2000-10-18 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075580-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2000-10-18 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075580-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2000-10-18 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075580-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2000-10-18 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075580-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2000-10-18 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075580-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2000-10-18 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A075580-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2000-10-18 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A075580-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2000-10-18 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A075580-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2000-10-18 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A075580-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2000-10-18 | d06236e962d9… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A075580-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A075580-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A075580-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A075580-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075580-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075580-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075580-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075580-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A075580-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A075580-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A075580-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A075580-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075580-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075580-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075580-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075580-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075580-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075580-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075580-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075580-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075580-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075580-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075580-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075580-004 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075580-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075580-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075580-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075580-004 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075580-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075580-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075580-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075580-004 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075580-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075580-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075580-003 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075580-004 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A075580-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A075580-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A075580-003 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A075580-004 | AB | 1 | d06236e962d9… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | bfea0b5b-9354-490f-88ff-008134077d24 | 2026-07-16 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | REMEDYREPACK INC. | bf2f7b41-f14d-4fcd-8db3-f507ca6ff78b | 2026-06-12 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | PD-Rx Pharmaceuticals, Inc. | 2ea9bb6b-a4f0-496a-b27b-4454167a4b70 | 2026-05-13 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | Cardinal Health 107, LLC | 08521333-ff21-45ad-b99e-1f43d945d24d | 2026-04-24 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | REMEDYREPACK INC. | 30a6bb83-f91b-4c4f-a849-4f2be3735a0e | 2026-04-14 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | Preferred Pharmaceuticals Inc. | 2110eec5-949d-4718-ad6d-3629e5db8a07 | 2026-04-08 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | Preferred Pharmaceuticals Inc. | e046e0b7-f510-4318-9884-034d683864d4 | 2026-04-08 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | AvPAK | de9ab9a4-d8b8-8b36-e053-2a95a90aaa35 | 2026-03-24 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | AvKARE | e3d381c1-3b2f-af70-f4e6-08d6202eed25 | 2026-03-24 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 54116886-ea5e-5320-e054-00144ff8d46c | 2026-02-16 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | 54549d19-6311-4dbb-8622-fd3e5440551a | 2026-01-29 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | Northwind Health Company, LLC | f306adae-a2fe-5477-e053-2995a90a7838 | 2026-01-01 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | American Health Packaging | 3f4dc1a7-05e6-41d7-908c-30ce2677d87b | 2025-09-17 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | Apotex Corp. | 4fa5c2f7-cda9-56cd-622f-b3d05dc7c94b | 2025-09-17 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | Major Pharmaceuticals | 3354196f-bbcf-4bc5-94f6-e6e8e132acb1 | 2025-07-08 | Warnings, Adverse reactions | 075580 ANDA075580 0904-5523 |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 2e5cd8cb-7d43-e7af-e063-6294a90a310e | 2025-02-17 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 505d3c4c-5506-72cc-e054-00144ff88e88 | 2024-07-09 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | Proficient Rx LP | 1d8ff659-8129-4dca-9e8f-13b97240d1e1 | 2024-06-01 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | f1dc70f6-4329-46da-8990-7bd6eec9d37d | 2021-12-07 | Warnings, Adverse reactions | 075580 ANDA075580 |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 7e547752-a53a-4ad9-b70e-7cc2a1dd5d5d | 2018-03-06 | Warnings, Adverse reactions | 075580 ANDA075580 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOXAZOSIN MESYLATE | 2 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 86P6PQK0MU | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3354196f-bbcf-4bc5-94f6-e6e8e132acb1 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 07a517fc-5845-3816-0f81-0a121804ec9e | Product name | 6 | 20250107 |
| 171dd63c-7eea-ede4-c010-4c25ba0a1087 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0904-5523-61 | Doxazosin | 1 in 1 BLISTER PACK | TABLET | 1 | 13 | |
| 0904-5523-61 | Doxazosin | 100 in 1 CARTON | TABLET | 100 | 13 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-5523-60 | EA - Each | 0904-5523 | 31afe72d-93b1-4d63-9962-a20aca5615bb | 1 | 2013-05-02 |
| 0904-5523-61 | EA - Each | 0904-5523 | ac2a8de9-ab97-41db-a7df-f55c947daa0c | 1 | 2016-10-06 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| DOXAZOSIN MESYLATE | ACTIVE INGREDIENT | 86P6PQK0MU | DOXAZOSIN TABLET [MAJOR PHARMACEUTICALS] | 1 | |
| DOXAZOSIN | ACTIVE MOIETY | NW1291F1W8 | DOXAZOSIN TABLET [MAJOR PHARMACEUTICALS] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | DOXAZOSIN TABLET [MAJOR PHARMACEUTICALS] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | DOXAZOSIN TABLET [MAJOR PHARMACEUTICALS] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | DOXAZOSIN TABLET [MAJOR PHARMACEUTICALS] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | DOXAZOSIN TABLET [MAJOR PHARMACEUTICALS] | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197625 | doxazosin mesylate 1 MG Oral Tablet | PSN | 3354196f-bbcf-4bc5-94f6-e6e8e132acb1 | 13 |
| 197626 | doxazosin mesylate 2 MG Oral Tablet | PSN | 3354196f-bbcf-4bc5-94f6-e6e8e132acb1 | 13 |
| 197627 | doxazosin mesylate 4 MG Oral Tablet | PSN | 3354196f-bbcf-4bc5-94f6-e6e8e132acb1 | 13 |
| 197625 | doxazosin 1 MG Oral Tablet | SCD | 3354196f-bbcf-4bc5-94f6-e6e8e132acb1 | 13 |
| 197626 | doxazosin 2 MG Oral Tablet | SCD | 3354196f-bbcf-4bc5-94f6-e6e8e132acb1 | 13 |
| 197627 | doxazosin 4 MG Oral Tablet | SCD | 3354196f-bbcf-4bc5-94f6-e6e8e132acb1 | 13 |
| 197625 | doxazosin (as doxazosin mesylate) 1 MG Oral Tablet | SY | 3354196f-bbcf-4bc5-94f6-e6e8e132acb1 | 13 |
| 197626 | doxazosin (as doxazosin mesylate) 2 MG Oral Tablet | SY | 3354196f-bbcf-4bc5-94f6-e6e8e132acb1 | 13 |
| 197627 | doxazosin (as doxazosin mesylate) 4 MG Oral Tablet | SY | 3354196f-bbcf-4bc5-94f6-e6e8e132acb1 | 13 |
| 197626 | doxazosin mesylate 2 MG Oral Tablet | PSN | 08521333-ff21-45ad-b99e-1f43d945d24d | 6 |
| 197626 | doxazosin 2 MG Oral Tablet | SCD | 08521333-ff21-45ad-b99e-1f43d945d24d | 6 |
| 197626 | doxazosin (as doxazosin mesylate) 2 MG Oral Tablet | SY | 08521333-ff21-45ad-b99e-1f43d945d24d | 6 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0904-5523-61 | 00904552361 | 100 BLISTER PACK in 1 CARTON (0904-5523-61) / 1 TABLET in 1 BLISTER PACK | 100 blister pack | 2011-07-14 | 0000-00-00 | No | No | Current |